Study details
Enrolling now
Simethicone for Gas Relief After Bariatric Surgery
Madigan Army Medical Center
NCT IDNCT06812832ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
260
Study length
about 4 years
Ages
18–89
Locations
1 site in WA
About this study
Researchers are testing if simethicone helps reduce gas pain and bloating after bariatric surgery. The trial will involve adults undergoing procedures like sleeve gastrectomy or gastric bypass. Participants will receive either a placebo or simethicone 80 mg.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Placebo
- 2.Take Simethicone 80 MG
PhasePhase 4
DrugSimethicone 80 MG
Routeoral
Primary goalOpioid Use
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
Dermatological Agents (Surfactant Activity)
Drug routes
oral (Oral Capsule)
Endpoints
Primary: Opioid Use, Pain